2021 Q1 Form 10-Q Financial Statement

#000143169521000010 Filed on May 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q4 2020 Q1
Revenue $36.12M $30.55M $16.07M
YoY Change 124.81%
Cost Of Revenue $6.850M $5.286M $4.342M
YoY Change 57.76%
Gross Profit $29.27M $25.26M $11.73M
YoY Change 149.64%
Gross Profit Margin 81.04% 82.7% 72.98%
Selling, General & Admin $22.29M $9.528M $7.112M
YoY Change 213.41%
% of Gross Profit 76.15% 37.72% 60.65%
Research & Development $14.46M $10.19M $7.217M
YoY Change 100.3%
% of Gross Profit 49.38% 40.34% 61.55%
Depreciation & Amortization $260.0K $233.0K $200.0K
YoY Change 30.0%
% of Gross Profit 0.89% 0.92% 1.71%
Operating Expenses $36.75M $19.72M $14.33M
YoY Change 156.44%
Operating Profit -$7.473M $5.541M -$2.603M
YoY Change 187.09%
Interest Expense $0.00 $0.00 $46.00K
YoY Change -100.0%
% of Operating Profit 0.0%
Other Income/Expense, Net -$18.95M -$8.450M -$376.0K
YoY Change 4939.36%
Pretax Income -$26.42M -$2.909M -$2.979M
YoY Change 786.91%
Income Tax $36.00K $48.00K $47.00K
% Of Pretax Income
Net Earnings -$26.46M -$2.957M -$3.026M
YoY Change 774.32%
Net Earnings / Revenue -73.24% -9.68% -18.83%
Basic Earnings Per Share -$0.63 -$0.16
Diluted Earnings Per Share -$0.63 -$20.82K -$0.16
COMMON SHARES
Basic Shares Outstanding 41.86M shares 18.62M shares
Diluted Shares Outstanding 41.86M shares 18.62M shares

Balance Sheet

Concept 2021 Q1 2020 Q4 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $586.6M
YoY Change
Cash & Equivalents $586.6M $75.76M $29.44M
Short-Term Investments
Other Short-Term Assets $844.0K $806.0K
YoY Change
Inventory
Prepaid Expenses $1.831M $855.0K
Receivables $47.94M $45.64M
Other Receivables $0.00
Total Short-Term Assets $639.9M $125.2M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $2.206M $2.241M
YoY Change
Goodwill $0.00
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.600M $298.0K
YoY Change
Total Long-Term Assets $6.465M $9.180M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $639.9M $125.2M
Total Long-Term Assets $6.465M $9.180M
Total Assets $646.4M $134.4M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.151M $9.104M
YoY Change
Accrued Expenses $70.98M $42.58M
YoY Change
Deferred Revenue $1.016M $585.0K
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $78.14M $72.00M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $271.0K $329.0K
YoY Change
Total Long-Term Liabilities $271.0K $329.0K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $78.14M $72.00M
Total Long-Term Liabilities $271.0K $329.0K
Total Liabilities $81.13M $75.17M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$95.76M -$69.30M
YoY Change
Common Stock $147.0K $22.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $565.2M -$52.48M -$63.63M
YoY Change
Total Liabilities & Shareholders Equity $646.4M $134.4M
YoY Change

Cashflow Statement

Concept 2021 Q1 2020 Q4 2020 Q1
OPERATING ACTIVITIES
Net Income -$26.46M -$2.957M -$3.026M
YoY Change 774.32%
Depreciation, Depletion And Amortization $260.0K $233.0K $200.0K
YoY Change 30.0%
Cash From Operating Activities $4.209M $17.38M $3.684M
YoY Change 14.25%
INVESTING ACTIVITIES
Capital Expenditures $106.0K -$284.0K $80.00K
YoY Change 32.5%
Acquisitions $0.00
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$178.0K -$284.0K -$80.00K
YoY Change 122.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $506.8M -1.543M $14.90M
YoY Change 3301.89%
NET CHANGE
Cash From Operating Activities $4.209M 17.38M $3.684M
Cash From Investing Activities -$178.0K -284.0K -$80.00K
Cash From Financing Activities $506.8M -1.543M $14.90M
Net Change In Cash $510.8M 15.55M $18.50M
YoY Change 2660.99%
FREE CASH FLOW
Cash From Operating Activities $4.209M $17.38M $3.684M
Capital Expenditures $106.0K -$284.0K $80.00K
Free Cash Flow $4.103M $17.66M $3.604M
YoY Change 13.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001431695
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-40213
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
Olo Inc.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-2971562
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
285 Fulton Street
CY2021Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
World Trade Center
CY2021Q1 dei Entity Address Address Line3
EntityAddressAddressLine3
82nd Floor
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10007
CY2021Q1 dei City Area Code
CityAreaCode
212
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
260-0895
CY2021Q1 dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.001 per share
CY2021Q1 dei Trading Symbol
TradingSymbol
OLO
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
586566000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75756000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
719000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
631000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
47944000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
45641000 USD
CY2021Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
674000 USD
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
356000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
2047000 USD
CY2020Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
1830000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2675000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1661000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
639906000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
125244000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2206000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2241000 USD
CY2021Q1 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
610000 USD
CY2020Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
503000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
3351000 USD
CY2020Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
3346000 USD
CY2021Q1 olo Deferred Offering Costs Noncurrent
DeferredOfferingCostsNoncurrent
0 USD
CY2020Q4 olo Deferred Offering Costs Noncurrent
DeferredOfferingCostsNoncurrent
2792000 USD
CY2021Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
298000 USD
CY2020Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
298000 USD
CY2021Q1 us-gaap Assets
Assets
646371000 USD
CY2020Q4 us-gaap Assets
Assets
134424000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
6151000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9104000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
70976000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
42578000 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1016000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
585000 USD
CY2021Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 USD
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
19735000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
78143000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
72002000 USD
CY2021Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
375000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
435000 USD
CY2021Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2344000 USD
CY2020Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2402000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
271000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
329000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
81133000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
75168000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
0 shares
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
60509120 shares
CY2021Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2021Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
58962749 shares
CY2020Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
58962749 shares
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
111737000 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
147000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
22000 USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0 shares
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
660849000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16798000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-95758000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-69301000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
565238000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-52481000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
646371000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
134424000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36123000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16068000 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
6850000 USD
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
4342000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
29273000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
11726000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14456000 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7217000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18454000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4832000 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3836000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1014000 USD
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2280000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
36746000 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
14329000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7473000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2603000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
0 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
46000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-18000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11000 USD
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
18930000 USD
CY2020Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
341000 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-18948000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-376000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26421000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2979000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
36000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
47000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-26457000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26457000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3026000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3026000 USD
CY2021Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
14000 USD
CY2020Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
19000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-26471000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3045000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41855757 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41855757 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18617567 shares
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
111737000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18617567 shares
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
58962749 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-52481000 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
477826000 USD
CY2021Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
14000 USD
CY2021Q1 olo Adjustments To Additional Paid In Capital Temporary Equity Accretion To Redemption Value
AdjustmentsToAdditionalPaidInCapitalTemporaryEquityAccretionToRedemptionValue
14000 USD
CY2021Q1 olo Temporary Equity Issued During Period Shares Warrants Exercised
TemporaryEquityIssuedDuringPeriodSharesWarrantsExercised
1681848 shares
CY2021Q1 olo Temporary Equity Issued During Period Value Warrants Exercised
TemporaryEquityIssuedDuringPeriodValueWarrantsExercised
2000 USD
CY2021Q1 olo Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
39056000 USD
CY2021Q1 olo Temporary Equity Shares Conversion Of Convertible Securities
TemporaryEquitySharesConversionOfConvertibleSecurities
60644597 shares
CY2021Q1 olo Temporary Equity Value Conversion Of Convertible Securities
TemporaryEquityValueConversionOfConvertibleSecurities
111753000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
111753000 USD
CY2021Q1 olo Stock Issued During Period Value Charitable Donation
StockIssuedDuringPeriodValueCharitableDonation
5125000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2157000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5426000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-26457000 USD
CY2021Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
565238000 USD
CY2019Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
49371876 shares
CY2019Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
61901000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-61550000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
19000 USD
CY2020Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
19000 USD
CY2020Q1 olo Adjustments To Additional Paid In Capital Temporary Equity Accretion To Redemption Value
AdjustmentsToAdditionalPaidInCapitalTemporaryEquityAccretionToRedemptionValue
19000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
949000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3026000 USD
CY2020Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
49371876 shares
CY2020Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
61920000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-63627000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-26457000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3026000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
260000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
152000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5402000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
949000 USD
CY2021Q1 olo Share Based Payment Arrangement Vesting Of Stock Appreciation Rights Noncash Expense
ShareBasedPaymentArrangementVestingOfStockAppreciationRightsNoncashExpense
2847000 USD
CY2020Q1 olo Share Based Payment Arrangement Vesting Of Stock Appreciation Rights Noncash Expense
ShareBasedPaymentArrangementVestingOfStockAppreciationRightsNoncashExpense
0 USD
CY2021Q1 us-gaap Noncash Contribution Expense
NoncashContributionExpense
5125000 USD
CY2020Q1 us-gaap Noncash Contribution Expense
NoncashContributionExpense
0 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
88000 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
211000 USD
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
18930000 USD
CY2020Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
341000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2390000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11210000 USD
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
425000 USD
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
38000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-294000 USD
CY2021Q1 olo Increase Decrease In Capitalized Contract Costs
IncreaseDecreaseInCapitalizedContractCosts
222000 USD
CY2020Q1 olo Increase Decrease In Capitalized Contract Costs
IncreaseDecreaseInCapitalizedContractCosts
80000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6772000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6868000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
8524000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
8189000 USD
CY2021Q1 olo Increase Decrease In Deferred Rent Credit
IncreaseDecreaseInDeferredRentCredit
-58000 USD
CY2020Q1 olo Increase Decrease In Deferred Rent Credit
IncreaseDecreaseInDeferredRentCredit
611000 USD
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
371000 USD
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
423000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4209000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3684000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
178000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
80000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-178000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
18501000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-80000 USD
CY2021Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
485541000 USD
CY2020Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 USD
CY2021Q1 olo Proceeds Employee Payroll Tax Withholding
ProceedsEmployeePayrollTaxWithholding
19195000 USD
CY2020Q1 olo Proceeds Employee Payroll Tax Withholding
ProceedsEmployeePayrollTaxWithholding
0 USD
CY2021Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2020Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
15000000 USD
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
392000 USD
CY2020Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2021Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
448000 USD
CY2020Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
573000 USD
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2099000 USD
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
470000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
506779000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14897000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
510810000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29436000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
47000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75756000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10935000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
586566000 USD
CY2021Q1 olo Proceeds From Early Exercise Of Stock Options
ProceedsFromEarlyExerciseOfStockOptions
0 USD
CY2020Q1 olo Proceeds From Early Exercise Of Stock Options
ProceedsFromEarlyExerciseOfStockOptions
466000 USD
CY2021Q1 olo Issuance Costs Incurred But Not Yet Paid
IssuanceCostsIncurredButNotYetPaid
4476000 USD
CY2020Q1 olo Issuance Costs Incurred But Not Yet Paid
IssuanceCostsIncurredButNotYetPaid
1341000 USD
CY2021Q1 olo Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
58000 USD
CY2020Q1 olo Vesting Of Early Exercised Stock Options
VestingOfEarlyExercisedStockOptions
0 USD
CY2021Q1 olo Noncash Adjustments Temporary Equity Accretion To Redemption Value
NoncashAdjustmentsTemporaryEquityAccretionToRedemptionValue
14000 USD
CY2020Q1 olo Noncash Adjustments Temporary Equity Accretion To Redemption Value
NoncashAdjustmentsTemporaryEquityAccretionToRedemptionValue
19000 USD
CY2021Q1 olo Noncash Investing And Financing Options Exercised Cash Not Yet Received
NoncashInvestingAndFinancingOptionsExercisedCashNotYetReceived
0 USD
CY2020Q1 olo Noncash Investing And Financing Options Exercised Cash Not Yet Received
NoncashInvestingAndFinancingOptionsExercisedCashNotYetReceived
33000 USD
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
24000 USD
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
13000 USD
CY2021Q1 olo Share Based Compensation Arrangement Non Cash Expense Software Cost Capitalization
ShareBasedCompensationArrangementNonCashExpenseSoftwareCostCapitalization
24000 USD
CY2020Q1 olo Share Based Compensation Arrangement Non Cash Expense Software Cost Capitalization
ShareBasedCompensationArrangementNonCashExpenseSoftwareCostCapitalization
0 USD
CY2021Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentrations of Business and Credit RiskWe are exposed to concentrations of credit risk primarily through our cash held by financial institutions. We primarily deposit our cash with one financial institution and the amount on deposit exceeds federally insured limits. As of March 31, 2021 and December 31, 2020, 12% and 11% of our accounts receivable were due from one customer, respectively. For the three months ended March 31, 2021 and 2020, one customer accounted for 25% and 14% of our revenue, respectively.
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-indent:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></div><div style="margin-top:12pt;text-indent:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly assess these estimates, including but not limited to, allowance for doubtful accounts, stock-based compensation including the determination of the fair value of our stock, fair value of warrant liabilities, realization of deferred tax assets, estimated life of our customers, estimated standalone selling price of our performance obligations and estimated transaction price for implementation services. We base these estimates on historical experience and on various other market-specific and relevant assumptions that we believe to be reasonable under the circumstances. Actual results could differ from these estimates and such differences could be material to the financial position and results of operations.</span></div>
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36123000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16068000 USD
CY2021Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1300000 USD
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
900000 USD
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
100000 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
38800000 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.39
CY2021Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
400000 USD
CY2020Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
5176000 USD
CY2021Q1 olo Capitalized Contract Cost Additions
CapitalizedContractCostAdditions
875000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-653000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
5398000 USD
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4014000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3788000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1808000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1547000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2206000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2241000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
300000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
200000 USD
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1831000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
855000 USD
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
844000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
806000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2675000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1661000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25332000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5168000 USD
CY2021Q1 olo Accrued Delivery Service Fees Current
AccruedDeliveryServiceFeesCurrent
41237000 USD
CY2020Q4 olo Accrued Delivery Service Fees Current
AccruedDeliveryServiceFeesCurrent
34067000 USD
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
60509120 shares
CY2021Q1 olo Accrued Software Licensing Fees Current
AccruedSoftwareLicensingFeesCurrent
252000 USD
CY2020Q4 olo Accrued Software Licensing Fees Current
AccruedSoftwareLicensingFeesCurrent
237000 USD
CY2021Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1773000 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
909000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2382000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2197000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
70976000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
42578000 USD
CY2021Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
17
CY2021Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
17
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
67905561 shares
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
142693665 shares
CY2020Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
58962749 shares
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
58962749 shares
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
111737000 USD
CY2020Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
111888000 USD
CY2021Q1 olo Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Exercised Early
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberExercisedEarly
183651 shares
CY2020Q4 olo Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Exercised Early
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberExercisedEarly
204850 shares
CY2021Q1 us-gaap Deferred Compensation Sharebased Arrangements Liability Current And Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
500000 USD
CY2021Q1 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
200000 USD
CY2021Q1 us-gaap Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent
300000 USD
CY2021Q1 olo Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Issuance
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForIssuance
20383828 shares
CY2020Q4 olo Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Issuance
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForIssuance
46170691 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.10
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8249000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
949000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
39161438 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.93
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M20D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
347574000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
6759710 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.72
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1965824 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
333591 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.24
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
43621733 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
43621733 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.15
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.15
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y3M25D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y3M25D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1013813000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1013813000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
28423478 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.42
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y8M23D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
709782000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.50
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.22
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
53400000 USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
500000 USD
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
6000000.0 USD
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
7200000 USD
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
89600000 USD
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
29600000 USD
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1682847 shares
CY2021Q1 olo Class Of Warrant Or Right Exercises In Period
ClassOfWarrantOrRightExercisesInPeriod
1682847 shares
CY2021Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
19735000 USD
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
18930000 USD
CY2021Q1 olo Warrant Or Right Exercised
WarrantOrRightExercised
38665000 USD
CY2021Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 USD
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0014
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0159
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
28800000 USD
CY2021Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2021Q1 olo Lessee Operating Lease Rent Abatement Term
LesseeOperatingLeaseRentAbatementTerm
P11M
CY2021Q1 olo Lessee Operating Lease Term After Abatement With Consistent Rate
LesseeOperatingLeaseTermAfterAbatementWithConsistentRate
P5Y
CY2021Q1 olo Lessee Operating Lease Rental Payment Percent Increase Decrease
LesseeOperatingLeaseRentalPaymentPercentIncreaseDecrease
0.06
CY2021Q1 olo Lessee Operating Lease Rate Increase Term After Abatement
LesseeOperatingLeaseRateIncreaseTermAfterAbatement
P5Y
CY2021Q1 olo Lessee Operating Lease Liability Security Deposit
LesseeOperatingLeaseLiabilitySecurityDeposit
1400000 USD
CY2021Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
1300000 USD
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
800000 USD
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
800000 USD
CY2021Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
100000 USD
CY2020Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
100000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2636000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3533000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3352000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2780000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2885000 USD
CY2021Q1 olo Lessee Operating Lease Liability Payments Due Thereafter Year Four
LesseeOperatingLeaseLiabilityPaymentsDueThereafterYearFour
13074000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
28260000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-26457000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-3026000 USD
CY2021Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
14000 USD
CY2020Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
19000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-26471000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-26471000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3045000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3045000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41855757 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41855757 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18617567 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18617567 shares
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
43661603 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
132116945 shares
CY2021Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
300000 USD
CY2020Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
600000 USD
CY2021Q1 us-gaap Accounts Receivable Related Parties
AccountsReceivableRelatedParties
200000 USD
CY2020Q4 us-gaap Accounts Receivable Related Parties
AccountsReceivableRelatedParties
400000 USD

Files In Submission

Name View Source Status
0001431695-21-000010-index-headers.html Edgar Link pending
0001431695-21-000010-index.html Edgar Link pending
0001431695-21-000010.txt Edgar Link pending
0001431695-21-000010-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
olo-20210331.htm Edgar Link pending
olo-20210331.xsd Edgar Link pending
olo-20210331_cal.xml Edgar Link unprocessable
olo-20210331_def.xml Edgar Link unprocessable
olo-20210331_g1.jpg Edgar Link pending
olo-20210331_htm.xml Edgar Link completed
olo-20210331_lab.xml Edgar Link unprocessable
olo-20210331_pre.xml Edgar Link unprocessable
olo10q-exhibit321.htm Edgar Link pending
q1202110qceoex-311.htm Edgar Link pending
q1202110qcfoex312.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending